Project Grant R21HD114955

Award Date 8/7/24
Completion Date 8/6/26
Dollars Obligated $253K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
East Lansing, MI 48824, USA
Similar Awards
The National Institute of Child Health and Human Development (NICHD) awarded a $759,944 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to Nextgenjane Inc., a women's health startup in Oakland, California. The grant supports the development and validation of a non-invasive, genomic-based diagnostic test for endometriosis using menstrual fluid samples. Nextgenjane has created a specialized menstrual fluid collection system and preliminary...
This federal Project Grant award, valued at $643,049.00 and issued by the National Institute of Child Health and Human Development (NICHD) under CFDA Program 93.865 Child Health and Human Development Extramural Research, will fund the development of a physiomimetic model of the endometrioma lesion microenvironment at the University of Illinois. The research aims to investigate the multicellular interactions and tissue tropism that drive the initiation and invasion of endometriotic lesions, which...
The federal Project Grant award SB1HD118921 was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865). The $2,045,782 award, granted on April 10, 2025, is supporting the development of ENDO-205, a novel, non-hormonal therapeutic for endometriosis, a prevalent and debilitating women's health condition that currently lacks an effective cure. The project aims...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research, totaling $2,163,115, will fund research to disentangle the genetic mechanisms of endometriosis severity using single-cell multi-omics analysis. The award will support a collaborative, multidisciplinary research team to perform large-scale single-cell epigenomic profiling, dissect allele-specific gene regulation, and...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under CFDA Program 93.865 Child Health and Human Development Extramural Research, aims to identify the central and peripheral mechanisms underlying endometriosis pain and the changes in pain after lesion removal surgery. The $233,250 award, granted on April 1, 2025, will fund a study focused on examining the relationships between endometriosis pain, conditioned pain...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is funding research at the Morehouse School of Medicine to investigate the use of novel nitro-fatty acid-based STING inhibitors as a non-hormonal therapeutic approach for treating endometriosis. The $578,397 award, effective July 7, 2025 through March 31, 2030, will support pre-clinical studies to define the...
The National Institute of Child Health and Human Development (NICHD) has awarded a $423,985 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the University of Illinois to develop a novel non-invasive monitoring system for detecting placental dysfunction and associated pregnancy complications. The funding will support research to utilize extracellular vesicles (EVs) circulating in maternal blood as biomarkers, using a "target recycling...
This $506,000 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research supports research to define the structure-interactome relationships of the basigin glycoprotein in endometriosis. The awardee, Scripps Research Institute, will apply proximity labeling technologies to map the interactome of basigin, a glycoprotein that contributes to endometriosis, in cell culture models. This...
This federal Project Grant award for $131,085 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support research to gain a better understanding of the role of uterine natural killer (UNK) cells in the pathobiology of endometriosis. The primary objectives are to characterize the receptor repertoire and functional capacity of UNK cells in women with and without endometriosis,...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), funds the development and validation of a machine learning-based fetal monitoring system to predict and prevent fetal hypoxia. The $261,310 award will support the creation of a high-sensitivity, high-specificity predictive model using a multi-site dataset of 50,000 fetal monitoring tracings coupled with...

This Project Grant award of $252,678 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research, aims to develop a novel, non-invasive gas sensor technology for early detection of endometriosis.

The key products and services to be delivered include: 1) Detecting and distinguishing endometriosis vs. healthy cells by analyzing volatile organic compound (VOC) mixtures from 2D and 3D cell cultures, and comparing performance to the gold standard GC-MS technology; and 2) Quantifying the brain-based sensor's ability to detect urinary VOC profiles from a healthy vs. endometriosis mouse model during disease progression. The long-term goal is to transition this "disease sniffing neuron" technology into a sensitive, reliable, real-time, and portable exhaled breath-based endometriosis screening device. This award spans the period from August 2024 to August 2026 and is a collaborative effort between Henry Ford Health and Michigan State University Health Sciences.

Generated 8/5/25, 2:48 AM